logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 7 of 7 Items
Showing 1 - 7 of 7 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II)

Schmid C, Richer M, Bilenge CM, Josenando T, Chappuis F,  et al.
2005-06-01 • Journal of Infectious Diseases
2005-06-01 • Journal of Infectious Diseases
BACKGROUND: Treatment of late-stage human African trypanosomiasis (HAT) with melarsoprol can be improved by shortening the regimen. A previous trial demonstrated the safety and efficacy ...
Conference Material
|
Abstract

Understanding and improving case management of severe febrile illness in highly malaria-endemic settings: an observational implementation study in the Democratic Republic of the Congo, Nigeria and Uganda

Signorell A, Hetzel M, Tshefu AK, Omoluabi E, Awor P,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
INTRODUCTION
In sub-Saharan Africa, over 400,000 children die annually from malaria and other preventable illnesses. Little is known about where these children die, from which causes...
Journal Article
|
Research

Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies

Burri C, Yeramian PD, Allen JL, Merolle A, Serge KK,  et al.
2016-02-16 • PLOS Neglected Tropical Diseases
2016-02-16 • PLOS Neglected Tropical Diseases
BACKGROUND
Sleeping sickness (human African trypanosomiasis [HAT]) is caused by protozoan parasites and characterized by a chronic progressive course, which may last up to several ye...
Journal Article
|
Research

Treatment of human African trypanosomiasis--present situation and needs for research and development

Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C,  et al.
2002-07-01 • Lancet Infectious Diseases
2002-07-01 • Lancet Infectious Diseases
Human African trypanosomiasis re-emerged in the 1980s. However, little progress has been made in the treatment of this disease over the past decades. The first-line treatment for second-...
Conference Material
|
Slide Presentation

Understanding and improving case management of severe febrile illness in highly malaria-endemic settings an observational implementation study in the Democratic Republic of the Congo, Nigeria and Uganda

Signorell A, Hetzel M, Tshefu AK, Omoluabi E, Awor P,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
Journal Article
|
Commentary

Human African trypanosomiasis

Brun R, Blum J, Chappuis F, Burri C
2009-10-14 • Lancet
2009-10-14 • Lancet
Human African trypanosomiasis (sleeping sickness) occurs in sub-Saharan Africa. It is caused by the protozoan parasite Trypanosoma brucei, transmitted by tsetse flies. Almost all cases a...
Journal Article
|
Commentary

Human African trypanosomiasis [review]

Brun R, Blum J, Chappuis F, Burri C
2010-01-09 • Lancet
2010-01-09 • Lancet